Board approves Q1 FY27 results: revenue up 12% YoY, profit falls 21%

Ebitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.6%Reaction day

₹27.28

prior close

₹27.99

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+1.3% vs market

Commodity Chemicals peers, median of 52sector-0.5%+3.1% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 3.1 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.6+1.3+1.3-0.5+3.1

Next day

+2.3+1.6+0.6-0.6+2.9

+1.0+1.7-0.7-1.3+2.3

—+1.6—-0.8—

-4.0+1.5-5.4-1.3-2.7

-2.5+1.8-4.4-1.4-1.1

-7.4+2.1-9.4-0.0-7.3

15d

—+3.2—-1.4—

-4.3+3.7-8.0+0.4-4.7

-4.5+1.1-5.6+0.7-5.2

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 52Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Link Pharma Chem reported Q1 FY27 revenue from operations of 876.84 lakh, up 12.2 percent from 781.48 lakh in Q1 FY26. Profit after tax declined to 31.83 lakh from 40.19 lakh, a drop of about 21 percent YoY. Total income stood at 911.73 lakh versus 802.40 lakh. The result marks a recovery from a loss of 40.86 lakh posted in Q4 FY26. EBITDA margin compressed to about 8.8 percent from 10.6 percent YoY. EPS for the quarter was 0.72 versus 0.91. Statutory auditor CNK and Associates LLP issued a clean review report. Revenue is from single segment, manufacture and sale of chemicals.

Likely market impact

Mixed picture. Recovery from Q4 loss is positive, but YoY profit decline and weaker margins may dampen investor sentiment.